5 European Projects Found
Searched on 125080 European Projects
FINISHED
Multi-dimensional omics approach to stratification of patients with low back pain (PAIN-OMICS)
Start date: Sep 1, 2013, End date: Aug 31, 2018,
"Pain-OMICS is a multidisciplinary consortium of leading clinical, academic and SME researchers in pain and different omics technologies. Genome-wide association studies identified a number of loci associated with pain, but the level of knowledge about underlying mechanisms of different pain syndromes as well as individual variation in the disease course remains inadequate. Pain-OMICS will capital ...
Read Project
11
Partners Participants
FINISHED
Diagnostic and prognostic biomarkers for inflammatory bowel disease IBD-BIOM (IBD-BIOM)
Start date: Oct 1, 2012, End date: Sep 30, 2016,
...IBD are unsatisfactory. Development of biomarkers allowing insights into pathogenesis, prognosis and targeted therapy is a major unmet need. This programme addresses that need. IBD-BIOM is a multidisciplinary consortium of leading academic and industrial SME researchers in inflammatory bowel disease, genomics, glycomics, glycoproteomics and activomics. Recent genome-wide association studies perfor ...
Read Project
11
Partners Participants
FINISHED
Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)
Start date: Sep 1, 2013, End date: Aug 31, 2016,
...frican trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (California) and South America (Brazil) with high throughpu ...
Read Project
14
Partners Participants
FINISHED
Transferring Activomics into the Clinical Setting (TACTICS)
Start date: Dec 1, 2015, End date: May 31, 2016,
...jor toll on public health and a concomitant heavy economic burden for the healthcare system and taxpayer. Better diagnosis and targeted therapy of IBD would reduce suffering and costs alike. We participate in this call in order to achieve this goal, allowing us to devise a comprehensive business plan that will act as a roadmap to bring our biomarker into clinical diagnostic laboratories. SME-phase ...
Read Project
1
Partner Participant
FINISHED
Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LEISHDRUG)
Start date: Oct 1, 2008, End date: Mar 31, 2012,
...ct promastigote stage and the vertebrate aflagellate amastigote stage that proliferates inside infected host macrophages provoking the pathology of the disease. This consortium uses a highly interdisciplinary approach to reveal Leishmania signaling molecules associated with amastigote virulence, with the major aim to exploit parasite-specific pathways for anti-leishmanial drug development. We use ...
Read Project
